rs200497189
Variant summary
The NM_021625.5(TRPV4):c.616C>T (p.Arg206Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene TRPV4 is a known oncogene (CancerMine: 6 oncogene, 3 driver citations). The gene TRPV4 is a cancer driver gene (CancerMine: 6 oncogene, 3 driver citations). The variant allele was found at a cumulative frequency of 0.0000445 (AC=65) in the gnomAD database across 1,461,830 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000154. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R206H: Uncertain_significance (ClinVar VariationId 684495, 2 stars); p.R206L: Uncertain_significance (ClinVar VariationId 1320389, 2 stars) The variant has been observed in cBioPortal in 3 samples across 3 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Nevi and Melanomas; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_021625.5 missense
Scores
Clinical Significance
Conservation
Publications
- metatropic dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- neuromuscular diseaseInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- spondylometaphyseal dysplasia, Kozlowski typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- TRPV4-related bone disorderInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Illumina
- autosomal dominant brachyolmiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Charcot-Marie-Tooth disease axonal type 2CInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- scapuloperoneal spinal muscular atrophy, autosomal dominantInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- familial avascular necrosis of femoral headInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial digital arthropathy-brachydactylyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neuronopathy, distal hereditary motor, autosomal dominant 8Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 0 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
No applied criteria Uncheck "Show applied only" above to review all 20 criteria. | |||
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_021625.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TRPV4 | MANE Select | c.616C>T p.Arg206Cys | missense | Exon 4 of 16 | Prot: NP_067638.3 | |
TRPV4 | c.514C>T p.Arg172Cys | missense | Exon 4 of 16 | Prot: NP_001170902.1 UniProt: | ||
TRPV4 | c.616C>T p.Arg206Cys | missense | Exon 3 of 14 | Prot: NP_001170899.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TRPV4 | TSL:1MANE Select | c.616C>T p.Arg206Cys | missense | Exon 4 of 16 | Prot: ENSP00000261740.2 UniProt: | |
TRPV4 | TSL:1 | c.616C>T p.Arg206Cys | missense | Exon 3 of 15 | Prot: ENSP00000406191.2 UniProt: | |
TRPV4 | TSL:1 | c.514C>T p.Arg172Cys | missense | Exon 4 of 16 | Prot: ENSP00000444336.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000263 | AC:4 | Hom:0 | AN:152194 | Cov:32 |
GnomAD2 exomes | AF: 0.0000716 | AC:18 | AN:251228 | ||
GnomAD4 exome | AF: 0.0000445 | AC:65 | Hom:0 | AN:1461830 | Cov:34 |
GnomAD4 genome | AF: 0.0000263 | AC:4 | Hom:0 | AN:152312 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000189 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000316 | AC:7 | Hom:0 | AN:221622 | |
Local & regional cohorts 3 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.000427 | AC:1 | Hom:0 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.0000985 | ||||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000223 | AC:2 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00 * | 0 | 1490 | 0.000139 * | 1 | 7190 |
BipEx | 0.0000704 | 2 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.0000477 | 2 | 41958 | 0.0000897 | 6 | 66888 |
SCHEMA | 0.0000449 | 5 | 111306 | 0.0000709 | 13 | 183414 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 20 | |
AlphaMissense | Benign | 0.098 | |
BayesDel_addAF | Benign | -0.12 | T |
BayesDel_noAF | Benign | -0.12 | |
CADD | Pathogenic | 26 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.68 | D |
Eigen | Benign | 0.13 | |
Eigen_PC | Benign | 0.080 | |
FATHMM_MKL | Benign | 0.46 | N |
FuncVEP CTI | Benign | 0.015 | |
GPN-Star LLR | N/A | -5.2 | |
GPN-Star score | N/A | 5.2 | |
LIST_S2 | Benign | 0.74 | T |
M_CAP | Uncertain | 0.18 | D |
MetaRNN | Benign | 0.28 | T |
MetaSVM | Uncertain | 0.51 | D |
Mutation Taster | N/A | 54/46 | polymorphism |
MutationAssessor | Benign | 1.8 | L |
PhyloP100 | Benign | 2.0 | |
popEVE | Benign | -3.3 | |
PrimateAI | Benign | 0.37 | T |
PROVEAN | Uncertain | -3.6 | D |
REVEL | Uncertain | 0.54 | |
Sift | Uncertain | 0.011 | D |
Sift4G | Uncertain | 0.037 | D |
Varity_R | N/A | 0.22 | |
VESM-3B | Benign | -8.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.